Anyone who believes the current pps is the result of a short attack is not following the fundamentals of this company. The last conference call was a diaster when Gulfo discussed usage. Not only was usage a lowly twice daily for most of the derms with a melafind device, the usage was averaging a lowly 10 days per month. Even on the small universe of Derms reporting higher usage, their usage was on average only 13 days per month. At this conference call Gulfo went on to indicate that income by the end of the year will be running only $500 thousand per month, resulting in continued substantial short falls in cash flow. At best we will continue to go sideways until such time as both placements and usage increase substantially. The shorts are not influencing cash flows, poor management is.